1-3 of 3
Marcy A. List
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

Ezra E.W. Cohen, Madeleine A. Kane, Marcy A. List, Bruce E. Brockstein, Bhoomi Mehrotra, Dezheng Huo, Ann M. Mauer, Carolyn Pierce, Allison Dekker, Everett E. Vokes
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8418–8424.
https://doi.org/10.1158/1078-0432.CCR-05-1247
Published: 01 December 2005
View article titled, Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck
Open the PDF for Phase II Trial of Gefitinib 250 mg Daily in Patients with Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in another window
Journal Articles

Induction Chemotherapy followed by Concomitant TFHX Chemoradiotherapy with Reduced Dose Radiation in Advanced Head and Neck Cancer

Daniel J. Haraf, Fred R. Rosen, Kerstin Stenson, Athanassios Argiris, Bharat B. Mittal, Mary Ellyn Witt, Bruce E. Brockstein, Marcy A. List, Louis Portugal, Harold Pelzer, Ralph R. Weichselbaum, Everett E. Vokes
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5936–5943.
Published: 15 December 2003
View article titled, Induction Chemotherapy followed by Concomitant TFHX Chemoradiotherapy with Reduced Dose Radiation in Advanced Head and Neck Cancer
Open the PDF for Induction Chemotherapy followed by Concomitant TFHX Chemoradiotherapy with Reduced Dose Radiation in Advanced Head and Neck Cancer in another window
Journal Articles

Multicenter Randomized Phase II Study of Paclitaxel (1-Hour Infusion), Fluorouracil, Hydroxyurea, and Concomitant Twice Daily Radiation with or without Erythropoietin for Advanced Head and Neck Cancer

Fred R. Rosen, Daniel J. Haraf, Merrill S. Kies, Kerstin Stenson, Louis Portugal, Marcy A. List, Bruce E. Brockstein, Bharat B. Mittal, Alfred W. Rademaker, Mary Ellyn Witt, Harold Pelzer, Ralph R. Weichselbaum, Everett E. Vokes
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (5): 1689–1697.
Published: 01 May 2003
View article titled, Multicenter Randomized Phase II Study of Paclitaxel (1-Hour Infusion), Fluorouracil, Hydroxyurea, and Concomitant Twice Daily Radiation with or without Erythropoietin for Advanced Head and Neck Cancer
Open the PDF for Multicenter Randomized Phase II Study of Paclitaxel (1-Hour Infusion), Fluorouracil, Hydroxyurea, and Concomitant Twice Daily Radiation with or without Erythropoietin for Advanced Head and Neck Cancer in another window